Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2025-03-26 00:00:00 ET · period of report 2025-03-24 · accession 0001819790-25-000061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-03-26 | 2025-03-24 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $50.00 | -6,000 | 824.1K | -0.7% | -$300.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | S | D | 6,000 | $50.00 | 824,106 | I By the Bobak Azamian Living Trust established April 16, 2018 | — | — | (F2) The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. |